急性感染期静脉铁治疗缺铁性贫血的真实世界回顾性研究
本研究利用TriNetX研究网络(2000年至2025年6月)开展回顾性队列研究,评估急性感染成人缺铁性贫血患者静脉铁输注的安全性和疗效。
要点
- 急性感染期静脉铁治疗与14天和90天生存率显著提高相关。
- 静脉铁组60-90天血红蛋白恢复显著优于未用铁组。
- 各感染类型均未显示静脉铁加重感染的证据。
核心结论
- 急性感染期静脉铁治疗不加重感染,与生存改善和贫血恢复增强相关。
研究设计与样本
- 回顾性队列研究,使用TriNetX研究网络(2000年至2025年6月)数据。
- 纳入成人缺铁性贫血合并感染(MRSA菌血症、肺炎、尿路感染、结肠炎或蜂窝织炎)患者。
- 患者须在感染2天内接受抗生素治疗,按静脉铁暴露分层,各队列内进行1:1倾向性匹配。
临床怎么用
- 对急性感染合并缺铁性贫血的住院成人,静脉铁治疗可能改善生存和贫血恢复。
- 需前瞻性研究确认上述发现并扩大适用性。
局限性
- 回顾性研究设计,需前瞻性研究确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The administration of IV iron to treat anemia during acute infection remains controversial owing to concerns of exacerbating the infection. We conducted a retrospective cohort study using the TriNetX Research Network (2000 to June 2025) to evaluate the safety and efficacy of IV iron administration in adults with iron deficiency anemia and infection (methicillin-resistant Staphylococcus aureus [MRSA] bacteremia, pneumonia, urinary tract infection [UTI], colitis, or cellulitis). Patients must have received antibiotic agents within 2 days of infection for inclusion and were stratified by IV iron exposure. Propensity matching (1:1) was performed within each cohort. Survival was significantly higher (P< .001 for each infection type) at both 14 and 90 days in patients who received IV iron (MRSA bacteremia, 97.6% vs 95.0% and 88.6% vs 83.8%; pneumonia, 95.7% vs 91.5% and 84.7% vs 78.1%; UTI, 97.6% vs 95.7% and 89.1% vs 85.6%; colitis, 97.6% vs 95.5% and 89.7% vs 83.8%; and cellulitis, 98.5% vs 97.4% and 92.2% vs 89.2%). Hemoglobin recovery 60 to 90 days after infection was significantly greater (all P< .001) when IV iron was administered across all subgroups (MRSA bacteremia, +1.3 vs +1.0 g/dL; pneumonia, +1.3 vs +1.0 g/dL; UTI, +1.4 vs +1.0 g/dL; colitis, +1.5 vs +0.7 g/dL; and cellulitis, +1.4 vs +0.9 g/dL). The findings observed for each infection type studied suggest that IV iron administration during acute infection does not exacerbate infection and is associated with improved survival and enhanced recovery from anemia in hospitalized patients. Prospective studies are needed to confirm these findings and expand their applicability.
引用
- Sohail H, Collins JE, Chan KH, et al. A retrospective, real-world study of IV iron use to treat iron deficiency anemia during acute infection. Blood. 2026. PMID: 41592284. doi:10.1182/blood.2025031965
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。